ZYNERBA PHARMACEUTICALS INC's ticker is ZYNE and the CUSIP is 98986X109. A total of 60 filers reported holding ZYNERBA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.01 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $527,000 | +160.9% | 113,437 | +85.3% | 0.00% | +50.0% |
Q4 2020 | $202,000 | -2.4% | 61,218 | -2.3% | 0.00% | -33.3% |
Q3 2020 | $207,000 | -57.6% | 62,645 | -56.7% | 0.00% | -62.5% |
Q2 2020 | $488,000 | +369.2% | 144,760 | +739.0% | 0.01% | +700.0% |
Q4 2019 | $104,000 | +15.6% | 17,254 | +44.9% | 0.00% | 0.0% |
Q3 2019 | $90,000 | -32.3% | 11,909 | -51.3% | 0.00% | 0.0% |
Q1 2019 | $133,000 | +9.9% | 24,453 | +64.5% | 0.00% | 0.0% |
Q3 2018 | $121,000 | -9.7% | 14,861 | +8.1% | 0.00% | -50.0% |
Q2 2018 | $134,000 | -46.0% | 13,742 | -30.7% | 0.00% | -50.0% |
Q4 2017 | $248,000 | – | 19,843 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ETF MANAGERS GROUP, LLC | 3,662,342 | $7,874,000 | 0.16% |
IQ EQ FUND MANAGEMENT (IRELAND) Ltd | 213,469 | $438,000 | 0.07% |
GSA CAPITAL PARTNERS LLP | 150,914 | $309,000 | 0.04% |
Bernardo Wealth Planning LLC | 30,469 | $62,000 | 0.03% |
Penserra Capital Management LLC | 351,154 | $719,000 | 0.02% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 175,900 | $361,000 | 0.01% |
Founders Capital Management | 3,000 | $9,000 | 0.01% |
King Wealth Management Group | 16,000 | $33,000 | 0.01% |
Aquatic Capital Management LLC | 1,900 | $4,000 | 0.01% |
Newbridge Financial Services Group, Inc. | 6,075 | $12,000 | 0.01% |